Skip to content

Studying the Role of Homeopathic Medicines in Reducing Mild Depression: A Comparison with Placebo

Effectiveness of individualized homoeopathic medicine in the management of mild depression- A placebo controlled experimental study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094176
Enrollment
84
Registered
2025-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F410- Panic disorder [episodic paroxysmal anxiety]

Interventions

Intervention1: Individualized homoeopathic constitutional medicine[GroupT] Trial group[subjects MD1,MD2,MD3 and so on]: Individualized homoeopathic constitutional medicine based on similia similibus c

Sponsors

Dr GD Pol Foundation YMT Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) The patient having PHQ-9 Score: 5-9 indicates mild depression. 2) Adults aged above 18 yrs. 3) All the genders. 4) All socioeconomic status. 5]consent given

Exclusion criteria

Exclusion criteria: I) Patient suffering from or history of other psychiatric illness. II) Pregnancy or lactating womans. III) Patient having any co-morbidity. IV) Patient taking other mode of treatment. V)Patient with suspected immunocompromised disease and medical and surgical emergencies . consent not given

Design outcomes

Primary

MeasureTime frame
measured using the PHQ-9 scale to assess effectiveness of individualized homoeopathic medicine compared to placebo.Timepoint: Each patient will be assessed at the baseline,4weeks,8weeks. [of commencement of treatment, after every 4 weeks during treatment and at the end of the treatment(12 months ) or if remission occurs, which ever is earlier ]

Secondary

MeasureTime frame
1]To identify the most frequently indicated individualized homeopathic medicines in the treatment of mild depression 2]To evaluate the duration required for significant symptomatic improvement in mild depression using individualized Homoeopathic medicine as compared to placebo. 3)To evaluate pre & post PHQ-9 score up to 12 months if remission occurs which ever earlier. Timepoint: 1]baseline,4 weeks ,8 weeks 2]baseline,4 weeks ,8 weeks 3]baseline,4 weeks ,8 weeks [Each patient will be assessed at the time of commencement of treatment, after every 4 weeks during treatment & at the end of the treatment(12 months ) or if remission occurs, which ever is earlier ].

Countries

India

Contacts

Public ContactDR YOGESHWAR RAMDASJI GAIKWAD

Dr .G.D Pol Foundation YMT Homoeopathic Medical College and Hospital

newbeginingsach@yahoo.com9172488888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026